225 related articles for article (PubMed ID: 8033369)
1. Urinary excretion of pyridinium cross-links in healthy women; the long-term effects of menopause and oestrogen/progesterone therapy.
Schlemmer A; Hassager C; Delmas PD; Christiansen C
Clin Endocrinol (Oxf); 1994 Jun; 40(6):777-82. PubMed ID: 8033369
[TBL] [Abstract][Full Text] [Related]
2. Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: a longitudinal and cross-sectional study.
Hassager C; Colwell A; Assiri AM; Eastell R; Russell RG; Christiansen C
Clin Endocrinol (Oxf); 1992 Jul; 37(1):45-50. PubMed ID: 1424192
[TBL] [Abstract][Full Text] [Related]
3. Posture, age, menopause, and osteopenia do not influence the circadian variation in the urinary excretion of pyridinium crosslinks.
Schlemmer A; Hassager C; Pedersen BJ; Christiansen C
J Bone Miner Res; 1994 Dec; 9(12):1883-8. PubMed ID: 7872053
[TBL] [Abstract][Full Text] [Related]
4. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links.
Uebelhart D; Schlemmer A; Johansen JS; Gineyts E; Christiansen C; Delmas PD
J Clin Endocrinol Metab; 1991 Feb; 72(2):367-73. PubMed ID: 1991806
[TBL] [Abstract][Full Text] [Related]
5. Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women.
Schlemmer A; Hassager C; Jensen SB; Christiansen C
J Clin Endocrinol Metab; 1992 Mar; 74(3):476-80. PubMed ID: 1740479
[TBL] [Abstract][Full Text] [Related]
6. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
[TBL] [Abstract][Full Text] [Related]
7. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
[TBL] [Abstract][Full Text] [Related]
8. Galactosylhydroxylysine and pyridinium cross links in monitoring the bone response to hormone replacement therapy.
Marabini R; Sirtori P; Chionna R; Barzizza L; Rubinacci A
J Endocrinol Invest; 1996 Mar; 19(3):154-8. PubMed ID: 8743280
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of pyridinium crosslinks in postmenopausal women and in Paget's disease of bone.
Sinigaglia L; Varenna M; Binelli L; Beltrametti P; Zucchi F; Arrigoni M; Frignani S; Abbiati G
Calcif Tissue Int; 1997 Oct; 61(4):279-84. PubMed ID: 9312197
[TBL] [Abstract][Full Text] [Related]
10. Effect of hormone replacement therapy on the bone mass and urinary excretion of pyridinium cross-links.
Pardini DP; Sabino AT; Meneses AM; Kasamatsu T; Vieira JG
Sao Paulo Med J; 2000 Jan; 118(1):3-6. PubMed ID: 10685120
[TBL] [Abstract][Full Text] [Related]
11. Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion.
Del Campo MT; González-Casaus ML; Aguado P; Bernad M; Carrera F; Martínez ME
Osteoporos Int; 1999; 9(5):449-54. PubMed ID: 10550465
[TBL] [Abstract][Full Text] [Related]
12. Urinary deoxypyridinoline is a useful biochemical bone marker for the management of postmenopausal osteoporosis.
Yu SL; Ho LM; Lim BC; Sim ML
Ann Acad Med Singap; 1998 Jul; 27(4):527-9. PubMed ID: 9791660
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis.
Fledelius C; Riis BJ; Overgaard K; Christiansen C
Calcif Tissue Int; 1994 May; 54(5):381-4. PubMed ID: 8062154
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of the pyridinium cross-links of collagen in systemic lupus erythematosus.
Kipen Y; Will R; Strauss BJ; Morand EF
Clin Rheumatol; 1998; 17(4):271-6. PubMed ID: 9776107
[TBL] [Abstract][Full Text] [Related]
15. The Urinary Excretion of Pyridinium Cross-links as Markers of Bone Meta stasisin Breast Cancer.
Hiraide H; Okamura S; Hayashi T; Nishida M; Tamaki K; Tamakuma S
Breast Cancer; 1994 Dec; 1(2):103-108. PubMed ID: 11091517
[TBL] [Abstract][Full Text] [Related]
16. Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemia.
Body JJ; Delmas PD
J Clin Endocrinol Metab; 1992 Mar; 74(3):471-5. PubMed ID: 1740478
[TBL] [Abstract][Full Text] [Related]
17. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion.
Garnero P; Gineyts E; Arbault P; Christiansen C; Delmas PD
J Bone Miner Res; 1995 Apr; 10(4):641-9. PubMed ID: 7610936
[TBL] [Abstract][Full Text] [Related]
18. Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis.
Toussirot E; Ricard-Blum S; Dumoulin G; Cedoz JP; Wendling D
Rheumatology (Oxford); 1999 Jan; 38(1):21-7. PubMed ID: 10334678
[TBL] [Abstract][Full Text] [Related]
19. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
20. The effect of hormone replacement therapy in postmenopausal women on urinary C-telopeptide and N-telopeptide of type I collagen, new markers of bone resorption.
Taga M; Uemura T; Minaguchi H
J Endocrinol Invest; 1998 Mar; 21(3):154-9. PubMed ID: 9591210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
